Announced details
Treatment of nausea and vomiting associated with pregnancy
Approved and widely used in 45 countries worldwide
Mochida Pharmaceutical entered into an agreement with Duchesnay in December 2025 covering development and sales in Japan.
Headquartered in Quebec, Canada. A specialty pharmaceutical company focused on women’s health and a member of Duchesnay Pharmaceutical Group. President: Éric Gervais.
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists (eds.), Guidelines for Obstetrical Practice in Japan 2026
| Item | Details |
|---|---|
| Names of Products / Services Covered | BON-001, Bonjesta |
| Counterparty | Duchesnay Inc. |
| Counterparty overview | Headquartered in Quebec, Canada. A specialty pharmaceutical company focused on women’s health and a member of Duchesnay Pharmaceutical Group. President: Éric Gervais. |
| Relationship with the Company | Mochida Pharmaceutical entered into an agreement with Duchesnay in December 2025 covering development and sales in Japan. |
| Contract Date | December 2025 |
| Applicable area | Treatment of nausea and vomiting associated with pregnancy |
| Usage history | Approved and widely used in 45 countries worldwide |
| Source | Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists (eds.), Guidelines for Obstetrical Practice in Japan 2026 |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To verify the efficacy and confirm the safety of the product. The aim is also to address the drug loss of treatment options and provide a new treatment option for nausea and vomiting associated with pregnancy, for which no approved treatment is currently available in Japan.